MARCKS protein overexpression is associated with poor prognosis in male breast cancer.
Auteurs
Manai M, Abdeljaoued S, Goucha A, Adouni O, Bettaieb I, Bouzaien H, Rahal K, Birnbaum D, Bertucci F, Gamoudi A
Résumé
Male breast cancer (MBC) is a rare and aggressive disease. Thus, identification of new therapeutic targets is crucial.
Lire l‘article